2012
DOI: 10.1016/j.clineuro.2012.03.044
|View full text |Cite
|
Sign up to set email alerts
|

Decompressive craniectomy after intravenous tissue plasminogen activator administration for stroke

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
15
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 23 publications
(17 citation statements)
references
References 12 publications
2
15
0
Order By: Relevance
“…Several other studies have failed to find a significant effect of tPA administration on poor outcome and mortality after surgery as well. 2,6,28 In the present study 29% of patients received intravenous tPA prior to DH. Although the theoretical risk of increased bleeding during and after the procedure exists, cases involving tPA intervention or endovascular therapy should not exclude the need for DH.…”
Section: Discussionmentioning
confidence: 99%
“…Several other studies have failed to find a significant effect of tPA administration on poor outcome and mortality after surgery as well. 2,6,28 In the present study 29% of patients received intravenous tPA prior to DH. Although the theoretical risk of increased bleeding during and after the procedure exists, cases involving tPA intervention or endovascular therapy should not exclude the need for DH.…”
Section: Discussionmentioning
confidence: 99%
“…Fibrinolytics promote the transformation of plasminogen into plasmin, thereby accelerating the degradation of the fibrin clot. The plasminogen recombinant tissue activator (r-TPA), used in our country, has a half-life of 5 min, however, it is considered that the fibrinolytic effect persists for more than 24 hours Three publications have been published in recent years that demonstrate that the performance of intravenous or intra-arterial fibrinolytics does not increase the risk of hemorrhagic complications in patients undergoing decompressive craniectomies, even when this is done in the first 24 hours after the administration of these drugs [19][20][21].…”
Section: Journal Of Universal Surgery Issn 2254-6758mentioning
confidence: 99%
“…Surgery can be safely performed even after intravenous tissue plasminogen activator administration for thrombolysis [38, 39]. The side of the stroke does not seem to affect the vital status after surgical decompression, so it should not influence the choice to operate [32, 40].…”
Section: Best Conditions For Surgerymentioning
confidence: 99%